Literature DB >> 21305473

Reprogramming cell fate to pluripotency: the decision-making signalling pathways.

Daniela Sanges1, Maria-Pia Cosma.   

Abstract

Pluripotency can be defined as the ability of individual cells to initiate all of the lineages of the mature organism in response to signals from the environment. It has long been assumed that during development, pluripotency is progressively and irreversibly lost through a mechanism that requires strict coordination of the signalling pathways involved in cell proliferation, differentiation and migration. However, recent breakthroughs have highlighted evidence that terminally differentiated cells can be reprogrammed into pluripotent stem cells, prompting a re-evaluation of the reversibility of cell differentiation. Generations of pluripotent cells can arise from somatic cells following ectopic expression of specific transcription factors; however, these factors might well not be the unique essential reprogramming factors. Furthermore, they can be the end-point targets of signalling pathways. Indeed, recent evidence shows that modulation of the Wnt/beta-catenin, MAPK/ERK, TGF-beta or PI3K/Akt signalling pathways strikingly enhances somatic-cell reprogramming. Nevertheless, we still know relatively little about the underlying mechanisms by which somatic cells de-differentiate to pluripotency. In this review, we provide an overview of the signalling pathways promoting the re-acquisition and maintenance of pluripotency and we discuss the possible mechanisms underlying nuclear reprogramming.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21305473     DOI: 10.1387/ijdb.103190ds

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  12 in total

1.  Comparative analysis of nuclear transfer embryo-derived mouse embryonic stem cells. Part II: gene regulation.

Authors:  Julianna Kobolak; Marion Horsch; Sandra Geissler; Solomon Mamo; Johannes Beckers; Andras Dinnyes
Journal:  Cell Reprogram       Date:  2011-12-28       Impact factor: 1.987

2.  Transcriptome profiling and in silico analysis of somatic embryos in Japanese larch (Larix leptolepis).

Authors:  Yuan Zhang; Shougong Zhang; Suying Han; Xinmin Li; Liwang Qi
Journal:  Plant Cell Rep       Date:  2012-05-24       Impact factor: 4.570

3.  HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.

Authors:  M He; Q-Y Wang; Q-Q Yin; J Tang; Y Lu; C-X Zhou; C-W Duan; D-L Hong; T Tanaka; G-Q Chen; Q Zhao
Journal:  Cell Death Differ       Date:  2012-10-12       Impact factor: 15.828

4.  PTEN regulates lung endodermal morphogenesis through MEK/ERK pathway.

Authors:  Yiming Xing; Runming Wang; Changgong Li; Parviz Minoo
Journal:  Dev Biol       Date:  2015-10-13       Impact factor: 3.582

Review 5.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells.

Authors:  P Dentelli; C Barale; G Togliatto; A Trombetta; C Olgasi; M Gili; C Riganti; M Toppino; M F Brizzi
Journal:  Diabetologia       Date:  2012-10-12       Impact factor: 10.122

7.  A genome-wide RNAi screen reveals MAP kinase phosphatases as key ERK pathway regulators during embryonic stem cell differentiation.

Authors:  Shen-Hsi Yang; Tuzer Kalkan; Claire Morrisroe; Austin Smith; Andrew D Sharrocks
Journal:  PLoS Genet       Date:  2012-12-13       Impact factor: 5.917

8.  Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming.

Authors:  Dilip Dey; Gregory R D Evans
Journal:  Stem Cells Int       Date:  2011-10-05       Impact factor: 5.443

9.  Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors.

Authors:  Daniela Sanges; Giacoma Simonte; Umberto Di Vicino; Neus Romo; Isabel Pinilla; Marta Nicolás; Maria Pia Cosma
Journal:  J Clin Invest       Date:  2016-07-18       Impact factor: 14.808

10.  Cisplatin induces differentiation of breast cancer cells.

Authors:  Praseetha Prabhakaran; Foteini Hassiotou; Pilar Blancafort; Luis Filgueira
Journal:  Front Oncol       Date:  2013-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.